Which are the causes of Antisynthetase syndrome?

Antisynthetase syndrome is a chronic autoimmune condition where the body’s immune system mistakenly attacks its own tissues, triggered by the production of specific autoantibodies, most notably anti-Jo-1. While the exact root cause remains unknown, it is widely understood as a complex interaction between a person’s genetic predisposition and external environmental factors that "switch on" an overactive immune response.

What triggers the development of Antisynthetase syndrome?

The primary mechanism underlying Antisynthetase syndrome is an autoimmune response directed against aminoacyl-tRNA synthetases, which are enzymes essential for protein synthesis within cells. In a healthy body, the immune system distinguishes "self" from "non-self." In patients with Antisynthetase syndrome, this surveillance system fails, leading to the creation of autoantibodies that damage muscles, lungs, and joints. Think of these autoantibodies as "misguided security guards" that begin attacking the body's own infrastructure instead of protecting it.

Is Antisynthetase syndrome a hereditary condition?

Antisynthetase syndrome is not considered a classic hereditary disease caused by a single gene mutation passed directly from parent to child. Instead, research suggests a polygenic susceptibility—meaning an individual may inherit a combination of genes that makes their immune system more prone to developing autoimmune disorders. While your genetic makeup may increase your vulnerability, it does not guarantee the development of the condition, as other external triggers are typically required to initiate the disease process.

What are the known risk factors for Antisynthetase syndrome?

While the exact etiology is still under investigation, researchers have identified several factors that may increase the risk of developing Antisynthetase syndrome:

• Viral Infections: Some clinical evidence suggests that certain viral infections might "mimic" the structure of tRNA synthetase enzymes, tricking the immune system into attacking the body's own cells (a process called molecular mimicry).


• Environmental Exposure: Chronic inhalation of dust, silica, or certain pollutants is being studied as a potential trigger, particularly because the lungs are often the first organ system affected in Antisynthetase syndrome.


• Hormonal Factors: Like many autoimmune diseases, there is a higher prevalence among women, suggesting that hormonal pathways may play a role in modulating immune system activity.


• Microchimerism: Some theories suggest that foreign cells (such as those from a fetus during pregnancy) may persist in the body and trigger an immune reaction years later.

How is current research improving our understanding of the causes?

The medical community is currently focusing on "epigenetics"—the study of how environmental factors can change the way genes are expressed without altering the DNA sequence itself. By studying the 36 community members and other patients on platforms like DiseaseMaps.org, researchers are better able to map the clinical progression of Antisynthetase syndrome. Current research is heavily invested in identifying biomarkers that could predict disease flare-ups or lung involvement before significant damage occurs, moving us closer to personalized, precision medicine.

Next steps

• Consult a rheumatologist or a pulmonologist specializing in interstitial lung disease (ILD) to manage systemic symptoms.


• Keep a detailed diary of potential environmental exposures or illness patterns to share with your clinical team.


• Connect with the 36 members of the Antisynthetase syndrome community at DiseaseMaps.org to share experiences and coping strategies.


• Ask your physician about participating in clinical trials or registries that focus on the underlying biology of idiopathic inflammatory myopathies.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Antisynthetase syndrome overview.


• Orphanet: Rare disease database entry for Antisynthetase syndrome (ORPHA: 85145).


• PubMed/NCBI: Current literature on the pathophysiology of anti-tRNA synthetase antibodies.


• The Myositis Association: Educational resources on inflammatory myopathies.